Company intelligence / Profile preview

CABYC

San Sebastián de los Reyes, Madrid, Spaincabyc.com ↗

Ownership: Private
Development stage: Commercial

Overview

No published results from proprietary programs. As a CRO sponsor/collaborator, involved in at least four registered clinical trials including late-stage oncology studies.

Therapeutic areas: NephrologyOncologyEndocrinologyWomen's HealthImmunologyRare DiseasesHematologyPsychiatryDermatologyRheumatologyGastroenterologyCardiovascularOphthalmologyNeurologyInfectious Diseases
Modalities: Gene therapyPeptidesSmall molecule drugs
Industry: Contract Research Organization

Partnerships

European biotech group for gene therapy platformsInternational multidisciplinary scientific group for anti-infective peptides

Beyond the preview

Go deeper on CABYC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CABYC.

Explore the full profile